难治性特发性血小板减少性紫癜的治疗进展(6)
[28]Faiz Anwer，Seongseok Yun，Anju Nair，et al.Severe Refractory Immune Thrombocytopenia Successfully Treated with High-Dose Pulse Cyclophosphamide and Eltrombopag[J].Case Reports in Hematology，2015(9)：583451.
[29]Stirnemann J，Kaddouri N，Khellaf M，et al.Vincristine efficacy and safety in treating immune thrombocytopenia：a retrospective study of 35 patients[J].European Journal of Haematology，2016，96(3)：269-275.
[30]Gasbarrini A，Franceschi F，Tartaglione R，et al.Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori[J].Lancet，1998，352(9131)：878.
[31]Takahashi T，Yujiri T，Shinohara K，et al.Molecular mimicry by Heli-cobacter pylori CagA protein may be involved in the patho-genesis of H.pylori-associated chronic idiopathic throm-bocytopenic purpura[J].Br J Haematol，2004，124(1)：91-96.
[32]Veneri D，Matteis GD，Solero P，et al.Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura：correlation with Helicobacter pylori infection and response to eradication treatment[J].Platelets，2005，16(5)：307-311.
[33]Asahi A，Kuwana M，Suzuki H，et al.Therapeutic action of Helicobacter pylori eradication patients with chronic ITP-Lessons from eradication therapy on H.pylori-negative patients[J].Blood，2004，92(2)：563-570.
[34]Semple JW，Aslam R，Kim M，et al.Platelet-bound lipopolysaccharide enhances Fc receptor mediated phagocytosis of IgG-opsonized platelets[J].Blood，2007，109(11)：4803-4805.
[35]張励，马茉娇，刘小宇，等.幽门螺旋杆菌感染与Hp的相关性研究[J].临床军医杂志，2011，39(6)：1272-1273.
[36]Takafuta T，Fujimura K.Helicobacter pylori(H.pylori)Eradication[J].Autoimmune Thrombocytopenia，2017：135-143.
[37]Fujimura K，Kuwana M，Kurata Y，et al.Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura.Analysis of 207 eradicated chronic ITP cases in Japan[J].Int J Hematol，2005，81(2)：162-168.
[38]Hwang JJ，Lee DH，Yoon H，et al.The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura[J].Gut Liver，2016，10(3)：356-361., 百拇医药(唐培渊 宋俊峰 秦克乐 王寻 阎雄)
[29]Stirnemann J，Kaddouri N，Khellaf M，et al.Vincristine efficacy and safety in treating immune thrombocytopenia：a retrospective study of 35 patients[J].European Journal of Haematology，2016，96(3)：269-275.
[30]Gasbarrini A，Franceschi F，Tartaglione R，et al.Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori[J].Lancet，1998，352(9131)：878.
[31]Takahashi T，Yujiri T，Shinohara K，et al.Molecular mimicry by Heli-cobacter pylori CagA protein may be involved in the patho-genesis of H.pylori-associated chronic idiopathic throm-bocytopenic purpura[J].Br J Haematol，2004，124(1)：91-96.
[32]Veneri D，Matteis GD，Solero P，et al.Analysis of B- and T-cell clonality and HLA class II alleles in patients with idiopathic thrombocytopenic purpura：correlation with Helicobacter pylori infection and response to eradication treatment[J].Platelets，2005，16(5)：307-311.
[33]Asahi A，Kuwana M，Suzuki H，et al.Therapeutic action of Helicobacter pylori eradication patients with chronic ITP-Lessons from eradication therapy on H.pylori-negative patients[J].Blood，2004，92(2)：563-570.
[34]Semple JW，Aslam R，Kim M，et al.Platelet-bound lipopolysaccharide enhances Fc receptor mediated phagocytosis of IgG-opsonized platelets[J].Blood，2007，109(11)：4803-4805.
[35]張励，马茉娇，刘小宇，等.幽门螺旋杆菌感染与Hp的相关性研究[J].临床军医杂志，2011，39(6)：1272-1273.
[36]Takafuta T，Fujimura K.Helicobacter pylori(H.pylori)Eradication[J].Autoimmune Thrombocytopenia，2017：135-143.
[37]Fujimura K，Kuwana M，Kurata Y，et al.Is eradication therapy useful as the first line of treatment in Helicobacter pylori-positive idiopathic thrombocytopenic purpura.Analysis of 207 eradicated chronic ITP cases in Japan[J].Int J Hematol，2005，81(2)：162-168.
[38]Hwang JJ，Lee DH，Yoon H，et al.The Effects of Helicobacter pylori Eradication Therapy for Chronic Idiopathic Thrombocytopenic Purpura[J].Gut Liver，2016，10(3)：356-361., 百拇医药(唐培渊 宋俊峰 秦克乐 王寻 阎雄)